drugset / Trial / NCT00770445
Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the Anti-Inflammation Effects of Pioglitazone, twice daily (BID), and Pioglitazone/Metformin Combination Therapy BID in Type 2 Diabetes Subjects Treated with Insulin.
Timeline
- Start
- 2008-05
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 850 mg | Oral |
| Subject | Pioglitazone | Small molecule | 15 mg | Oral |
| Background | insulin glargine | Protein / enzyme biologic | — | — |